Standardized Platform with Human Skin Tissue for Drug Testing with Pascal Descargues Genoskin TRANSCRIPT
Download PDFJul 27, 2020
Pascal Descargues PhD, Founder and CEO, Genoskin talks about bringing the only living injectable human platform to the market to enable clinical testing of drugs for efficacy and toxicity by biotech and pharmaceutical companies. Their standardized platform uses real human skin tissue to test the consequences of drugs...
Jul 27, 2020
Pascal Descargues PhD, Founder and CEO, Genoskin talks about bringing the only living injectable human platform to the market to enable clinical testing of drugs for efficacy and toxicity by biotech and pharmaceutical companies. Their standardized platform uses real human skin tissue to test the consequences of drugs...
Dec 11, 2019
Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained. We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and...
Dec 11, 2019
Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained. We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and...
Dec 17, 2018
Jesús Martin-Garcia, CEO, GeNeuro discusses the need for new treatment approaches for multiple sclerosis (MS), a long lasting, often disabling disease of the central nervous system that affects 2.5 million people worldwide. GeNeuro is developing a potential new approach for treating disease progression, the largest...